Sign In

Liangfang Zhao, Ph. D. (赵良方)

Business Development Scientist | Healthcare and Biopharma

Dr. Liangfang Zhao, known for his expertise in the field of neuroscience and biomedical science, is a distinguished professional with a rich academic background and a diverse work history. With a Doctorate from the University of Connecticut and additional studies in healthcare innovation from Harvard Medical School, Dr. Zhao has honed his skills in biology and biological sciences during his academic journey. His academic pursuits started at Capital Normal University, followed by Beijing No.4 High School and Tsinghua University.

Highlights

Apr 18 · linkedin

#socialissues #inclusionanddiversity

Mar 25 · linkedin

"The genome encodes the basic blueprints, but it's the proteome, and activated proteome in particular, that does the work of carrying signals, regulating cell cycles and more."

Post-translational modifications such as phosphorylation drive and underpin nearly all cell signaling cascades and interactions that are aberrant in cancer and therapeutic resistance, yet phosphorylation events of low-abundance molecules are impossible to capture with traditional biochemistry assays.

At Theralink, we have invented technologies that enables targeted pathway-based proteomics assessment. The reverse phase protein microarray (RPPA) generates a functional map of activated cell signaling networks/pathways to provide one-stop support from biomarker discovery to clinical trials. It is also a robust CLIA LDT assay for physician treatment decision support.

Interested in learning real-world examples of how biopharmas have leveraged us to augment their R&D efficiency and predictability? Let’s connect! #research #science #clinicaltrials #cancerresearch #oncology #immunooncology #cancer #precisionmedicine #biopharma #biomarkers #proteomics #cancerbiology #immunotherapy #precisiononcology

Liangfang Zhao, Ph. D. (赵良方)
Add to my network

Location

Boston, Massachusetts, United States